U.S. Markets open in 1 hr 28 mins

CollabRx partners with Sengenics

CollabRx announced a partnership with Sengenics to provide turn-key diagnostic decision making solutions for Asian and global markets. Sengenics plans to incorporate CollabRx's interpretive content resources into its molecular cancer diagnostics tests and reports.